1. Home
  2. CYD vs COLL Comparison

CYD vs COLL Comparison

Compare CYD & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo China Yuchai International Limited

CYD

China Yuchai International Limited

HOLD

Current Price

$28.30

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$21.80

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYD
COLL
Founded
1951
2002
Country
Singapore
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
1998
2015

Fundamental Metrics

Financial Performance
Metric
CYD
COLL
Price
$28.30
$21.80
Analyst Decision
Strong Buy
Buy
Analyst Count
4
8
Target Price
★ $59.10
$49.00
AVG Volume (30 Days)
122.9K
★ 791.1K
Earning Date
08-07-2026
11-05-2026
Dividend Yield
★ 2.70%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $780,567,000.00
Revenue This Year
$13.33
$7.09
Revenue Next Year
$9.34
$1.31
P/E Ratio
$32.71
★ N/A
Revenue Growth
N/A
★ 23.62
52 Week Low
$28.65
$21.43
52 Week High
$61.48
$50.79

Technical Indicators

Market Signals
Indicator
CYD
COLL
Relative Strength Index (RSI) 27.60 28.89
Support Level N/A $21.65
Resistance Level $45.94 $23.69
Average True Range (ATR) 1.64 0.82
MACD -0.07 0.22
Stochastic Oscillator 2.08 19.91

Price Performance

Historical Comparison
CYD
COLL

About CYD China Yuchai International Limited

China Yuchai International Ltd is a Bermuda holding company that is a subsidiary of Singapore-based Hong Leong Asia. China Yuchai International operates through its majority-owned subsidiary Guangxi Yuchai Machinery Company, a China-based company that manufactures, assembles, and distributes diesel engines for various vehicles including trucks, buses, and cars, as well as construction and agricultural, marine, and power-generation equipment. It generates the majority of its sales from the Chinese market.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: